Quick Answer
Verrica Pharmaceuticals Inc. reported Common Stock Shares Outstanding of 17.18 million shares for the year ending 2025.
- Verrica Pharmaceuticals Inc. showed an increase of +87.2% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Verrica Pharmaceuticals Inc.'s annual report (Form 10-K), filed with the SEC on March 11, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2017 to 2025), Verrica Pharmaceuticals Inc.'s Common Stock Shares Outstanding has grown by 364.4%.
- Historical annual values: Fiscal year 2025: 17.18 million shares | Fiscal year 2024: 9.18 million shares | Fiscal year 2023: 42.41 million shares | Fiscal year 2022: 41.09 million shares | Fiscal year 2021: 27.52 million shares | Fiscal year 2020: 25.44 million shares | Fiscal year 2019: 25.79 million shares | Fiscal year 2018: 25.70 million shares | Fiscal year 2017: 3.70 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: